TPIDB > Principal Investigator
Principal Investigator
Linkou Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomics
Division of General Internal Medicine
Taipei Chang Gung Medical Foundation
(在職)
Division of Dermatology
Division of Others-Immunodermatology, Adverse drug reactions, Drug hypersensitivity, Pharmacogenomicspsoriasis,
Chang Gung Medical Foundation Chang Gung Memorial Hospital, Keelung
Division of Dermatology
更新時間：2023-10-24
鐘文宏Chung, Wen-Hung
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
chung1@cgmh.org.tw
Publication
82Publications
31
52. Yang CY, Dao RL, Lee TJ, Lu CW, Yang CH, Hung SI, Chung WH*. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology. 2011 Dec 6;77(23):2025-33. (SCI; IF=8.166; Clinical Neurology: 8/193)
32
51. Wei CH, Hui RCY, Chang CJ, Ho HC, Yang CH, Lin YJ, Chung WH*. Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol. 2011 Nov-Dec;21(6):930-7. (SCI; IF=2.069; Dermatology: 21/61)
33
50. Wei CY, Chung WH, Huang HW, Chen YT, Hung SI*. Direct interaction between HLA-B and carbamazepine activates T cells in Stevens-Johnson syndrome. J Allergy Clin Immunol. 2012 Jun;129(6):1562-9. (SCI; IF=12.485; Allergy: 1/25; Immunology: 5/151)
34
49. Chung WH*, Hung SI. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis. J Dermatol Sci. 2012 Apr 11. 66(3): 190-6. (SCI; IF=3.739; Dermatology: 7/61)
35
48. Ko JH, Chung WH*. Serum sickness. Lancet. 2013 Jan 19;381. (SCI; IF=44.022; Medicine, general & internal: 2/155)
36
47. Lin YT, Chang YC, Hui R CY, Yang CH, Hung SI, Chung WH*. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions. J Eur Acad Dermatol Venereol. 2013 Mar;27(3):356-64. (SCI; IF=3.029; Dermatology: 10/61)
37
46. Hung SI, Chung WH*. Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology. 2013 Apr 23;80(17):1621-2. Neurology. 2013 Apr 23;80(17):1621. (SCI; IF=8.166; Clinical Neurology: 8/193)
38
45. Hu CH, Chang NJ, Liu EK, Chuang SS, Chung WH, Yang JY*. SCORTEN and impaired renal function related to mortality of toxic epidermal necrolysis syndrome patients in the Asian population. J Eur Acad Dermatol Venereol. 2013 May; 27(5): 628-33. (SCI; IF=3.029; Dermatology: 10/61)
39
44. Wang CW, Chung WH, Cheng YF, Ying NW, Peck K, Chen YT, Hung SI*. A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders. J Allergy Clin Immunol. 2013 Sep;132(3):713-722. (SCI; IF=12.485; Allergy: 1/25; Immunology: 5/151)
40
43. Lee HY*, Chung WH. Toxic epidermal necrolysis: the year in review. Curr Opin Allergy CLin Immunol. 2013 Aug; 13(4):330-6. (SCI; IF=2.771; Allergy: 10/25; Immunology: 79/151)
